COVID 19 pandemic and lockdown: A double whammy for patients with thalassemia. Unprecedented times for patients with thalassemia

Main Article Content

Shruti Kakkar
a:1:{s:5:"en_US";s:7:"MBBS,MD";}

Vaneet Anand
Junior Consultant, Pediatric Hematology Oncology, Dayanand Medical College and Hospital,Ludhiana

Priyanka Dewan
Child Psychologist

Praveen Sobti
Director, Guru Teg Bahadur Sahib Charitable Hospital, Ludhiana.

Keywords

Thalassemia, Lockdown, Optimal management

Downloads

Download data is not yet available.
Abstract 380 | PDF Downloads 180

References

1. Singh, P. How COVID-19 is endangering the lives of Thalassemia patients. National Herald. (2020, May 8). Retrieved from https://www.nationalheraldindia.com

2. Prasad, Narayan, Mansi Bhatt, Sanjay K Agarwal, et al. The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India. Kidney International Reports 2020; 5, Issue 9, 1545 – 1550.

3. Dehshal, M. H., Hosoya, S., Bahremani, et al. COVID-19 and Thalassaemia in Iran. Thalassemia Reports, 2020; 10(1). https://doi.org/10.4081/thal.2020.9157.

4. Eleftheriou, A., Cannon, L., & Angastiniotis, M. Thalassaemia prior and consequent to COVID-19 pandemic. The perspective of Thalassaemia International Federation (TIF). Thalassemia Reports, 2020; 10(1). https://doi.org/10.4081/thal.2020.9138.

5. Panigrahi M, Swain TR, Jena RK, et al. Effectiveness of Deferasirox in Pediatric Thalassemia Patients: Experience from a Tertiary Care Hospital of Odisha. Indian J Pharmacol 2020; 52:172-8.

6. Dhamija M, Mahajan A, Kalra M, et al. Deferasirox in Indian children with thalassemia major: 3 years experience. Indian J Med Paediatr Oncol. 2013;34(1):16-20. doi:10.4103/0971-5851.113407.

Article Sidebar

PDF
Published
Jul 1, 2021
DOI https://doi.org/10.23750/abm.v92i3.10880

Article Details

How to Cite

1.
Kakkar S, Anand V, Dewan P, Sobti P. COVID 19 pandemic and lockdown: A double whammy for patients with thalassemia.: Unprecedented times for patients with thalassemia. Acta Biomed [Internet]. 2021 Jul. 1 [cited 2023 Mar. 22];92(3):e2021212. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/10880
Issue
Vol. 92 No. 3 (2021)
Section
CORRESPONDENCE - SPECIAL COVID19

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)